Harrow

(NASDAQ) HROW

Current Price$33.21

Market Cap$1.24B

Since IPO (2007)+284%

5 Year+268%

1 Year+16%

1 Month-18%

Harrow Financials at a Glance

Market Cap

$1.24B

Revenue (TTM)

$268.68M

Net Income (TTM)

-$14.96M

EPS (TTM)

-$0.41

P/E Ratio

-81.23

Dividend

$0.00

Beta (Volatility)

1.04 (Average)

Dividend

$0.00

Beta (Volatility)

1.04 (Average)

Price

$33.21

Volume

649,473

Open

$34.59

Price

$33.21

Volume

649,473

Open

$34.59

Previous Close

$33.19

Daily Range

$33.10 - $34.90

52-Week Range

$28.54 - $54.85

Estimated Earnings Date

Aug 10, 2026

Dividend

$0.00

Beta (Volatility)

1.04 (Average)

Price

$33.21

Volume

649,473

Open

$34.59

Previous Close

$33.19

Daily Range

$33.10 - $34.90

52-Week Range

$28.54 - $54.85

Estimated Earnings Date

Aug 10, 2026

HROW News

A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal?

Andy GouldMar 24, 2026

Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45%

Jonathan PoncianoNov 27, 2025

optometrist covering her patient’s eyes with an occluder during an eye exam

Why Shares of Harrow Health Are Jumping Wednesday

James HalleyJul 19, 2023

ophthalmologist eye doctor examines patient

Why Shares of Harrow Health Are Slumping Friday

James HalleyMay 12, 2023

HROW: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Harrow

Industry

Pharmaceuticals

Sector

Health Care

Employees

373

CEO

Mark L. Baum

Website

www.harrow.com

Headquarters

Nashville, TN 37205, US

HROW Financials

Key Financial Metrics (TTM)

Gross Margin

74%

Operating Margin

10%

Net Income Margin

-6%

Return on Equity

-35%

Return on Capital

Return on Assets

-4%

Earnings Yield

-1.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.24B

Shares Outstanding

37.28M

Volume

649.47K

Avg. Volume

770.36K

Financials (TTM)

Gross Profit

$204.37M

Operating Income

$38.61M

EBITDA

$57.52M

Operating Cash Flow

$43.86M

Capital Expenditure

-$887.00K

Free Cash Flow

$42.98M

Cash & ST Invst.

$72.93M

Total Debt

$251.98M

Harrow Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$44.20M

-7.6%

Gross Profit

$27.05M

-16.3%

Gross Margin

61.18%

N/A

Market Cap

$1.24B

N/A

Market Cap/Employee

$3.24M

N/A

Employees

382

N/A

Net Income

-$27.60M

-55.2%

EBITDA

-$16.50M

-146.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-$206.02M

-26.2%

Accounts Receivable

$101.26M

+31.0%

Inventory

$16.50M

+53.9%

Long Term Debt

$299.75M

+147.6%

Short Term Debt

$915.00K

-99.2%

Return on Assets

-3.57%

N/A

Return on Invested Capital

8.57%

N/A

Free Cash Flow

-$9.19M

-147.2%

Operating Cash Flow

-$8.99M

-145.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BLFSBioLife Solutions, Inc.

BLFSBioLife Solutions, Inc.$26.64-1.66%

KMTSKestra Medical Technologies, Ltd.

KMTSKestra Medical Technologies, Ltd.$19.40-5.13%

ALVOAlvotech

ALVOAlvotech$3.54-5.35%

COLLCollegium Pharmaceutical, Inc.

COLLCollegium Pharmaceutical, Inc.$33.38+2.11%

EVOEvotec SE

EVOEvotec SE$2.80-5.72%

AMPHAmphastar Pharmaceuticals, Inc.

AMPHAmphastar Pharmaceuticals, Inc.$19.74+5.56%

DVAXDynavax Technologies Corporation

DVAXDynavax Technologies Corporation$15.50+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$11.87-0.11%

Questions About HROW

What is the current price of Harrow?

Harrow is trading at $33.19 per share.

What is the 52-week range for Harrow?

Over the past 52 weeks, Harrow has traded between $28.54 and $54.85.

How much debt does Harrow have?

As of the most recent reporting period, Harrow reported total debt of $300.67M.

How much cash does Harrow have on hand?

Harrow reported $94.64M in cash and cash equivalents in its most recent financial results.

What is Harrow’s dividend yield?

Harrow does not currently have a dividend yield.

Harrow

Harrow Financials at a Glance

HROW News

A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal?

Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45%

Why Shares of Harrow Health Are Jumping Wednesday

Why Shares of Harrow Health Are Slumping Friday

HROW: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Harrow

HROW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Harrow Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HROW

What is the current price of Harrow?

What is the 52-week range for Harrow?

How much debt does Harrow have?

How much cash does Harrow have on hand?

What is Harrow’s dividend yield?

Premium Investing Services